Industry NewsQIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired with Lilly’s Investigational Cancer Compounds
Application NotesPathway-Targeted Metabolomic Analysis in Oral/Head and Neck Cancer Cells Using Ion Chromatography-Mass Spectrometry